Rogier Caluwé

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Atrial Fibrillation

Respiratory Syndrome Coronavirus

Top Venues

Journal of the American Society of Nephrology : JASN

Onze-Lieve-Vrouwziekenhuis vzw

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Onze-Lieve-Vrouwziekenhuis vzw Jan 01 2013

Belgium

Staff member :: Nephrology Dialysis Hypertension

Publications

An S De Vriese, Rogier Caluwé, Hans Van Der Meersch, Koen De Boeck, Dirk De Bacquer
Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial. Journal of the American Society of Nephrology : JASN 32 (6) (2021)
Jens Tomas Van Praet, Marijke Reynders, Dirk De Bacquer, Liesbeth Viaene, Melanie K Schoutteten, Rogier Caluwé, Peter Doubel, Line Heylen, Annelies V De Bel, Bruno Van Vlem, Deborah Steensels, An S De Vriese
Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study. Journal of the American Society of Nephrology : JASN (2021)
An S De Vriese, Rogier Caluwé, Lotte Pyfferoen, Dirk De Bacquer, Koen De Boeck, Joost Delanote, Didier De Surgeloose, Piet Van Hoenacker, Bruno Van Vlem, Francis Verbeke
Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study. Journal of the American Society of Nephrology : JASN 31 (1) (2019)